← Back to Search

Behavioral Intervention

Contingency Management + Cognitive Behavioral Therapy for Quitting Vaping

N/A
Recruiting
Led By Suchitra Krishnan-Sarin, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
Current diagnosis of psychosis or evidence of significant homicidal/suicidal risk
Current diagnosis of a significant mental health disorder that is not being treated by a mental health practitioner with either behavioral and/or pharmacological interventions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of treatment at week 4, 1, 3, 6, and 12 month

Summary

This trial aims to help teenagers who vape quit by using rewards and online counseling. The program targets teens aged 13-19 who want to stop vaping. It works by giving rewards for not vaping and providing counseling to change their behavior and thoughts about vaping.

Who is the study for?
This trial is for high school students aged 13-19 who regularly use e-cigarettes with nicotine and want to quit. They must be able to read and write, have no major mental health issues untreated, not use psychoactive drugs or antidepressants unless stable and monitored, not pregnant or lactating, and without substance dependence except mild cannabis use.
What is being tested?
The study tests a new program combining rewards (contingency management) with online video counseling (cognitive behavioral therapy) to help teenagers stop vaping. Participants will either receive this intervention or be in a control group that does not receive the treatment.
What are the potential side effects?
Since the interventions are behavioral therapies involving rewards and counseling sessions, there are no direct medical side effects like those from medication. However, participants may experience stress or anxiety related to quitting nicotine.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have psychosis or a high risk of harming myself or others.
Select...
I have an untreated significant mental health condition.
Select...
I am currently pregnant or breastfeeding.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of treatment at week 4, 1, 3, 6, and 12 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of treatment at week 4, 1, 3, 6, and 12 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in 7-day point prevalence abstinence

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Remote Contingency Management (CM) for nicotine abstinenceExperimental Treatment1 Intervention
Participants will be paid increasing amounts of payment for each negative saliva cotinine test.
Group II: ControlPlacebo Group1 Intervention
Participants will be paid for providing saliva nicotine test, regardless of whether the test is positive or negative.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Electronic Cigarette Use include Contingency Management (CM) and Cognitive Behavioral Therapy (CBT). CM reinforces positive behavior through rewards, providing tangible incentives for patients to quit vaping. CBT addresses the psychological aspects of addiction, helping patients develop coping strategies to manage cravings and triggers. This dual approach is effective for Electronic Cigarette Use patients as it combines motivation through rewards with essential psychological tools for maintaining long-term abstinence.

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,927 Previous Clinical Trials
3,031,632 Total Patients Enrolled
1 Trials studying Electronic Cigarette Use
American Heart AssociationOTHER
346 Previous Clinical Trials
4,971,072 Total Patients Enrolled
Suchitra Krishnan-Sarin, PhDPrincipal InvestigatorYale University
4 Previous Clinical Trials
172 Total Patients Enrolled

Media Library

Remote Contingency Management (CM) for nicotine abstinence (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04898075 — N/A
Electronic Cigarette Use Research Study Groups: Remote Contingency Management (CM) for nicotine abstinence, Control
Electronic Cigarette Use Clinical Trial 2023: Remote Contingency Management (CM) for nicotine abstinence Highlights & Side Effects. Trial Name: NCT04898075 — N/A
Remote Contingency Management (CM) for nicotine abstinence (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04898075 — N/A
~0 spots leftby Jan 2025